Background: c-Aminobutyric acid (GABA) type A receptors (GABA A Rs) locate at both synaptic and extrasynaptic membrane, which generate phasic and tonic inhibition, respectively. In spinal cord dorsal horn, the phasic inhibition produced by transient activation of synaptic GABA A Rs plays an important role in the gating control over nociceptive conveyance. Although extrasynaptic GABA A Rs that contain a5 subunits (a5-GABA A Rs) are also detectable in spinal dorsal horn, much less is known about the function of these receptors. Methods: The C fibre-evoked field potentials were recorded in superficial dorsal horn of spinal cord, and the effects of a5-GABA A R inverse agonist L-655708 on basal synaptic transmission and long-term potentiation (LTP) of C-fibre responses were examined. The possible changes of glutamate receptor function and pain sensitivity after a5-GABA A R inhibition were investigated by western blot and behavioural tests. Results: Inhibition of a5-GABA A Rs by L-655708 boosted the basal synaptic transmission and facilitated the induction of N-methyl-D-aspartate subtype glutamate receptors (NMDARs)-dependent LTP. L-655708 was found to enhance the phosphorylation and synaptic accumulation of NMDARs and a-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid receptors (AMPARs). Intrathecal L-655708 injection also decreased the pain thresholds of intact mice in a dose-dependent manner. Conclusions: a5-GABA A Rs were critical for the tonic inhibition of glutamatergic neurotransmission and plasticity in spinal dorsal horn. Significance: Tonic inhibition generated by a5-GABA A Rs is important for information processing. However, whether and how a5-GABA A Rs regulate the conveyance of nociceptive signals in spinal cord is largely unknown. Here, we revealed a negative control by a5-GABA A Rs over nociceptive transmission and plasticity.
Introduction
The c-Aminobutyric acid (GABA) type A receptors (GABA A Rs) are heteropentameric proteins that are composed of combinations of several classes of subunits (a1-6, b1-3, c1-3, d, e, h, p, q1-3) . As one of the major inhibitory receptors in nociceptive pathways, GABA A Rs play an important role in the regulation of pain transmission. Pharmacological blockage of GABA A Rs in spinal cord dorsal horn of intact animals is sufficient to evoke painful responses (Zhang et al., 2001; Malan et al., 2002; Cao et al., 2011) . Following peripheral tissue or nerve injuries, GABAergic inhibition is rapidly and persistently impaired (Moore et al., 2002; Coull et al., 2003) , which has been widely considered as one of the key contributors to pathological pain (Zeilhofer, 2008; Zeilhofer and Zeilhofer, 2008) . The enhancement of GABA A Rs-mediated chloride currents ameliorates pain sensitization in several animal models of pathological pain (Hwang and Yaksh, 1997; Kontinen and Dickenson, 2000; Malan et al., 2002; Gwak et al., 2006; Knabl et al., 2008; Munro et al., 2008 Munro et al., , 2011 Ralvenius et al., 2015) , although inconsistent results have also been obtained in some injury models (Anseloni and Gold, 2008; Munro et al., 2011; Bravo-Hernandez et al., 2014 .
It is well-known that distinct subunits confer to GABA A Rs different biological properties (Jacob et al., 2008) . GABA A Rs containing a1-3 subunits primarily localize at inhibitory postsynaptic membrane, which sense GABA transmitter released from presynaptic terminals to generate fast inhibitory synaptic responses (Jacob et al., 2008) . Selective activation of GABA A Rs containing a2 and/or a3 subunits results in pronounced analgesia against inflammatory and neuropathic pain (Knabl et al., 2008; Ralvenius et al., 2015) . In addition to localize at postsynaptic sites, GABA A Rs are densely expressed at extrasynaptic or perisynaptic membrane (Jacob et al., 2008) . These receptors have been identified to contain a5 or d subunits, which display a higher affinity for GABA than those clustering at inhibitory synapses (Jacob et al., 2008; Belelli et al., 2009 ). Extrasynaptic GABA A Rs continuously respond to ambient GABA at extracellular space and generate the tonic inhibition (Farrant and Nusser, 2005; Ataka and Gu, 2006) . The alteration in tonic inhibitory conductance has widespread implications for learning, memory and neuropsychiatric disorders (Brickley and Mody, 2012) .
Evidence has been accumulating that a5 and d subunits are enriched in pain-related spinal dorsal horn (Bonin et al., 2011; Ralvenius et al., 2015; Bravo-Hernandez et al., 2016) . In genetically modified mice, the benzodiazepine agonists that act specifically on a5 subunit-containing GABA A Rs (a5-GABA A Rs) alleviate pathological pain (Ralvenius et al., 2015) . However, there have been some studies illustrating that inhibition of a5-GABA A Rs produces an analgesic action against inflammatory and neuropathic pain (Munro et al., 2011; Bravo-Hernandez et al., 2014 . To better understand the role of a5-GABA A Rs in nociceptive processing, the current study used a5-GABA A R inverse agonist L-655708 to examine whether a5-GABA A R regulated the nociceptive synaptic transmission and plasticity in spinal cord dorsal horn.
Materials and methods

Animals, intrathecal injection and behavioural test
The experimental procedures were in accordance with the guidelines of the Animal Care and Use Committee of Lanzhou University. Male adult Sprague-Dawley rats (180-220 g) and Kunming mice (6-8 weeks) were provided by the Experimental Animal Center of Lanzhou University. The animals were housed two to three per cage with free access to food and water. All the experiments were conducted blindly to the experimenters without knowledge of the manipulations that the animals had received. For intrathecal drug delivery, the mice were held firmly by a pelvic girdle and a 30-gauge needle attached to a 25 lL microsyringe was inserted between L5-L6 vertebrae (Wang et al., 2016) . A sudden advancement of the needle accompanied by a slight flick of the tail was used as the indicator for the proper insertion into the subarachnoid space. The drugs in 5 lL volume were then injected slowly. To induce inflammatory pain, complete Freund's adjuvant (CFA; Sigma-Aldrich, St. Louis, MO, USA) in 10 lL volume was injected into the plantar surfaces of hindpaws. The pain sensitivity was measured as previously described (Wang et al., 2016) . In brief, the mice were placed on a clear glass plate. A beam of light was focused on the plantar surfaces of hindpaws to deliver heat stimuli, with the cut-off of 10 s. The time between the onset of heat application and paw withdrawal was recorded automatically as paw withdrawal latency (PWL). Every effort was made to minimize the number of animals tested and their sufferings.
Subcellular fractionation
Mice were deeply anaesthetized with sodium pentobarbital (80-90 mg/kg, intraperitoneally). After a laminectomy, the lumbar spinal cords were quickly removed into ice-cold artificial cerebrospinal fluid (ACSF; in mmol/L: 119.0 NaCl, 2.5 KCl, 2.5 CaCl 2 , 1.3 MgCl 2 , 1.0 NaH 2 PO4, 26.0 NaHCO 3 , 11.0 D-glucose, bubbled with 95% O 2 + 5% CO 2 , pH 7.4). The transverse slices (600 lm thickness) were cut on a Vibratome stage (Wang et al., 2016) . The dorsal quadrants were dissected out, incubated at 36-37°C with drugs for the indicated periods, and then lysed in the Lysis Buffer [10.0 mmol/L Tris-HCl, pH 7.6, 320.0 mmol/L sucrose, 5.0 mmol/L EDTA, and proteases/phosphatases inhibitors (10.0 mmol/L NaF, 1.0 mmol/L Na 3 VO 4 , 1.0 mmol/L phenylmethylsulphonyl fluoride and 1.0 mg/mL each of aprotinin, chymostatin, leupeptin, antipain and pepstatin)]. The homogenate was centrifuged at 1000 g for 10 min at 4°C to remove the nuclei and large debris (P1). The supernatant was further centrifuged at 10,000 g for 15 min to yield the crude synaptosomal fraction (P2). The P2 pellet was resuspended and incubated in the Lysis Buffer containing 0.5% Triton X-100 for 15 min before centrifugation at 32,000 g for 20 min to obtain the synaptosomal membrane fraction (P3), which is enriched with postsynaptic density marker PSD-95 (Snyder et al., 2005; Yang et al., 2009 ). The P3 pellet was homogenized in sodium dodecyl sulphate (SDS) sample buffer and boiled at 95°C for 5 min before processing.
To assay the total protein expression and phosphorylation (Li et al., 2015) , the spinal dorsal horn was homogenized in Radio-Immunoprecipitation Assay (RIPA) buffer (50.0 mmol/L Tris-HCl, pH 8.0, 150.0 mmol/L NaCl, 1.0 mmol/L EDTA, 1.0% NP-40, 0.1% SDS, 0.5% sodium deoxycholate and proteases/phosphatases inhibitors). After centrifugation at 14,000 g for 10 min, the supernatant was harvested and protein concentration was measured by using BCA protein assay kit (Pierce, Rockford, IL, USA).
Western blot
The equal amounts of protein samples (20 lg) were resolved on SDS-Polyacrylamide Gel Electrophoresis and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 5% non-fat milk for 30 min at room temperature before incubation overnight with primary antibodies at 4°C. After three washes with PBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, Baltimore, PA, USA) for 60 min at room temperature. The blots were visualized by Enhanced Chemiluminescence. The PVDF membranes were stripped with the stripping buffer (5.0 mmol/L Tris-HCl, pH 6.8, 2% SDS, 0.5% b-mercaptoethanol) at 50°C for 30 min and reprobed with distinct antibodies . The primary antibodies used in the present study included the rabbit polyclonal antibody against GluN2B, GluN2A, GluA1, phosphorylated GluN1 at Ser896 from Millipore (Temecula, CA, USA), mouse monoclonal antibody against GluN1 from BD Pharmingen (San Diego, CA, USA), mouse monoclonal antibody against b-actin from SigmaAldrich, rabbit polyclonal antibody against phosphorylated GluN2B at Ser1303 or phosphorylated GluA1 at Ser831 from Upstate Biotechnology (Lake Placid, NY, USA).
Electrophysiological recordings
Rats were deeply anesthetized with urethane (1.5 g/ kg, intraperitoneally). The trachea was cannulated and the animals breathed spontaneously. A catheter was inserted into the right femoral vein for intravenous infusion of saline at a rate of 0.8-1 mL/h, whereas the right femoral artery was cannulated to monitor the arterial blood pressure. Colorectal temperature was kept constant (37-38°C) by a feedback-controlled heating pad. The left sciatic nerve was dissected free for bipolar electrical stimulation with a silver hook electrode. The exposed nerves were covered with warm paraffin oil in a pool made of skin flaps. A laminectomy was performed to expose the lumbar enlargement of spinal cord. The rat was stabilized in a stereotaxic apparatus, and the dura mater was carefully incised longitudinally. An agarose pool was formed around the exposed spinal segment, which was covered with ACSF. The electrophysiological recordings were performed as described previously (Hu et al., 2006; Drdla-Schutting et al., 2012; Wang et al., 2016) . Briefly, the field potentials were recorded at the depth of 100-300 lm from the surface of spinal cord with a glass pipette (2-3 MΩ) filled with 135.0 mmol/L NaCl, 5.4 mmol/L KCl, 1.8 mmol/L CaCl 2 , 1.0 mmol/L MgCl 2 and 10.0 mmol/L HEPES (pH 7.4). Single square pulses (0.5-ms duration, 25 V, 1-min interval) were delivered to sciatic nerves as test stimuli. The low-frequency stimulation (LFS; 0.5-ms duration, 60 V, 2 Hz, 120 s) or suboptimal stimulation (0.5-ms duration, 60 V, 2 Hz, 60 s) was used to induce LTP (Drdla-Schutting et al., 2012) . The signals were filtered using a bandwidth of 0.1-1000 Hz and digitized at a sampling rate of 5 kHz with an A/ D converter (LAB-TRAX-4/16; WPI).
Drugs
Ethyl(S)-11,12,13,13a-Tetrahydro-7-methoxy-9-oxo-
benzenesulphonamide (TCN-201; Sigma) and Ifenprodil (Sigma) were dissolved in dimethyl sulphoxide (DMSO). The drugs were diluted with ACSF just before use (the final DMSO concentration was 0.1%), and applied directly onto the exposed area of spinal cord in a volume of 20 lL.
Statistical analysis
All data were represented as mean AE SEM. The area under the curve of C fibre-evoked field potential was determined offline by Labscribe2 software (WPI). The areas of five consecutive field potentials were averaged. The mean area before LFS delivery or drug application served as baseline. The basal C-fibre responses were analysed by paired Student t test. LTP was defined as more than 50% increase in synaptic responses that were maintained for at least 3 h post-LFS. LTP data were analysed by two-way analysis of variance (ANOVA). For Western blots, the scanned digital images were quantified by NIH Image J software. The relative immunoreactive density of each protein was calculated by the ratio of its signal to b-actin signal, whereas the phosphorylation level was determined by the ratio of the phosphorylation signal to non-phosphorylation signal. The Western blot data were analysed by unpaired Student t test. Behavioural data were analysed by paired Student t test. The criterion for statistical significance was p < 0.05.
Results
3.1 a5-GABA A R tonically inhibited C fibreevoked synaptic transmission onto spinal cord dorsal horn of rats
The test electrical stimulation (0.5-ms duration, 25 V, 60-s interval) was delivered onto sciatic nerves of rats, and the C fibre-evoked field potentials were recorded in superficial dorsal horn of spinal cord (Drdla-Schutting et al., 2012) . To investigate the possible influence of a5-GABA A R on the synaptic strength between C fibres and dorsal horn neurons, the a5-GABA A R inverse agonist L-655708 was applied onto spinal cord dorsum after 30-min recording of baseline. In these experiments, ACSF vehicle was used as control. Our data showed that spinal treatment with ACSF alone had no effect on C fibreevoked field potentials (Fig. 1A) . The area under the curves of C fibre responses exhibited no significant difference before and after ACSF application (Fig. 1A) . Spinal treatment with L-655708 (0.5 pmol), however, caused a gradual increase in synaptic transmission (Fig. 1B) . Compared to baseline, the area under the curves of C fibre responses became to be significantly higher at 25 min post-drug application (Fig. 1B) . At the end of 180-min recordings, the areas of C fibre responses were still higher than baseline values (Fig. 1B) . These data suggested that a5-GABA A R persistently suppressed the C fibremediated nociceptive transmission.
3.2 a5-GABA A R regulated the induction of longterm potentiation (LTP) in spinal dorsal horn
The low-frequency stimulation (LFS; 0.5-ms duration, 60 V, 2 Hz, 120 s) of sciatic nerves has been shown to induce LTP of C fibre-evoked field potentials, one of well-characterized forms of synaptic plasticity underlying hyperalgesia (Sandkuhler, 2009) . To test whether a5-GABA A R regulated LTP Figure 1 The a5 subunit-containing GABA A receptor (a5-GABA A R) inverse agonist L-655708 boosted the C fibre-evoked field potentials in spinal cord dorsal horn of rats. Artificial cerebrospinal fluid (ACSF) vehicle was used as control. The original traces were taken at the time points indicated by number 1 and 2. The horizontal bar indicated the period of ACSF (A) or L-655708 application (0.5 pmol; B). The areas under the curves of C fibre-evoked field potentials were plotted against time. n = 6 rats in each group. *p < 0.05 relative to baseline values. induction, we pretreated the spinal cord with L-655708 (0.5 pmol) or ACSF vehicle for 60 min before LFS delivery. As previously reported (DrdlaSchutting et al., 2012) , LFS induced robust LTP in ACSF-treated rats (Fig. 2) . This synaptic potentiation lasted for at least 3 h (Fig. 2) . Compared to ACSF control, inhibition of a5-GABA A R by L-655708 significantly enhanced the magnitudes of LTP (Fig. 2) , suggesting that the removal of a5-GABA A R-mediated tonic inhibition facilitated LTP induction in spinal dorsal horn.
3.3 a5-GABA A R negatively controlled the synaptic expression of glutamate receptors Convincing evidence has indicated that NMDARs play a pivotal role in LTP induction. Pharmacological inhibition of NMDARs totally abolishes the synaptic potentiation in spinal dorsal horn (Ruscheweyh et al., 2011; Sandkuhler and Gruber-Schoffnegger, 2012) . To test whether a5-GABA A R regulated LTP by modifying the synaptic function of NMDARs, we treated the spinal cord slices with L-655708 (20 nmol/L) for 30 min (Martin et al., 2009; Clarkson et al., 2010; Wang et al., 2012) , and then analysed the protein expression of NMDARs at synapses, a pool of receptors that closely correlates with the synaptic efficacy. Our data showed that a5-GABA A R inhibition by L-655708 was able to enhance the immunoreactive density of NMDA receptor GluN1 subunit at synaptosomal membrane fraction (Fig. 3A) . The synaptic content of GluN2B, one of the regulatory NMDARs subunits, was also increased by L-655708 (Fig. 3B) . GluN2A, another regulatory NMDARs subunit, underwent no detectable change after L-655708 application when compared to ACSF control (Fig. 3C) . In addition to NMDARs, AMPARs were also subjected to the regulation by a5-GABA A R. There was a significant increase in the synaptic concentration of AMPA receptor GluA1 subunit in L-655708-treated slices relative to ACSF control (Fig. 3D) . To test whether a5-GABA A R regulated the total protein levels of glutamate receptors, we immunoblotted the whole-cell lysates of spinal dorsal horns after inhibition of a5-GABA A R. Compared to ACSF control, L-655708 generated no influence on the total expression of GluN1 (Fig. 4A) . The protein levels of GluN2B (Fig. 4B ) and GluA1 subunit (Fig. 4C ) in L-655708-treated slices were also comparable to those in control slices. These data suggested that a5-GABA A R negatively controlled the synaptic accumulation of GluN2B-containing NMDARs and GluA1-containing AMPARs.
a5-GABA A R activity suppressed the phosphorylation of glutamate receptors
The synaptic distribution of glutamate receptors can be dynamically regulated by phosphorylation. Our data showed that L-655708 (20 nmol/L) treatment of spinal slices for 30 min caused a significant increase in GluN1 phosphorylation at Ser896 (Fig. 5A) , a critical event involved in the synaptic trafficking of NMDARs (Scott et al., 2003) . Coincident with GluN1 phosphorylation was an enhanced GluN2B phosphorylation at Ser1303 in L-655708-treated slices relative to ACSF-treated control ones (Fig. 5B ). Since a5-GABA A R also regulated the synaptic content of GluA1, we tested the possible effects of L-655708 on GluA1, finding that a5-GABA A R inhibition noticeably enhanced GluA1 phosphorylation at Ser831 (Fig. 5C ).
Selective inhibition of GluN2B receptor blocked LTP induction in L-655708-treated rats
Given that a5-GABA A R inhibition led to the synaptic accumulation of GluN2B receptors, we tested whether GluN2B contributed to LTP induction in L-655708-treated rats. To this end, L-655708 was first Figure 2 Inhibition of a5-GABA A R by L-655708 enhanced the magnitudes of long-term potentiation (LTP) of C fibre-evoked field potentials in spinal cord dorsal horn of rats in vivo. L-655708 (0.5 pmol) or artificial cerebrospinal fluid (ACSF) vehicle was used to treat the spinal cord for 60 min before low-frequency stimulation (LFS; arrow) was delivered onto sciatic nerves. The original traces were taken at the time points indicated by number 1 and 2. The horizontal bar indicated the period of ACSF or L-655708 application. The areas under the curves of C fibre-evoked field potentials were plotted against time. *p < 0.05 relative to ACSF control. n = 6 rats in each group. applied onto spinal cord dorsum for 30 min, followed by superimposition of GluN2B-selective antagonist ifenprodil (6 nmol). At this dose, ifenprodil has been shown to generate an effective alleviation of pathological pain . After 30-min treatment with ifenprodil, LFS was delivered to sciatic nerves. Our data showed that, compared to ACSF vehicle, ifenprodil significantly reduced the magnitude of LFS-induced increase in C-fibre responses (Fig. 6A ). GluN2A-selective antagonist TCN-201 (Edman et al., 2012) , however, had no effect on LTP. As shown in Fig. 6A , the C-fibre responses were potentiated to a similar extent in the presence of TCN-201 (0.2 nmol) as was seen with ACSF control (Fig. 6A) . Ifenprodil or TCN-201 per se did not affect the basal synaptic transmission (Fig. 6B) .
To confirm that LTP facilitation by L-655708 required GluN2B activity, we delivered suboptimal stimuli (60 s instead of 120 s at 2 Hz) onto sciatic nerves. This stimulation protocol failed to induce LTP in ACSF-treated control rats (Fig. 7) . However, a robust LTP was elicited in L-655708-treated rats (Fig. 7) . Spinal application of ifenprodil totally prevented suboptimal stimuli from inducing LTP (Fig. 7) , while GluN2A antagonist TCN-201 had no effect (Fig. 7) . These data suggested that GluN2B receptors contributed to the facilitating effect of L-655708 on LTP. 
Inhibition of a5-GABA A R by L-655708 evoked pain sensitization in intact mice
To reveal the role of a5-GABA A R in spinal nociceptive processing, we measured the possible changes of pain thresholds after intrathecal injection of L-655708. At the low dose of 0.025 pmol, L-655708 did not affect the paw withdrawal latencies (PWL) in response to noxious thermal stimuli (Fig. 8A) . When the dose of L-655708 was increased to 0.1 pmol, a marked decrease in PWL was observed at 60 min post-drug injection (Fig. 8A) . At a higher dose of 0.5 pmol, L-655708 evoked a significant reduction in PWL at 30 min after intrathecal injection (Fig. 8A) . The PWL values remained lower at 60 min after L-655708 application when compared to baseline (Fig. 8A ).
Spinal application of ACSF vehicle had no effect on the pain thresholds at each time point tested (Fig. 8A ). These data suggested that spinal a5-GABA A R exerted a tonic inhibition of pain sensitivity under physiological conditions. Peripheral injuries have been shown to impair GABAergic inhibition in spinal cord dorsal horn (Zeilhofer, 2008; Zeilhofer and Zeilhofer, 2008) , which represents an important mechanism underlying central sensitization. We found that L-655708 (0.5 pmol), when intrathecally given one day after intraplantar injection of Complete Freund's Adjuvant (CFA), generate no effect on inflammatory hyperalgesia (Fig. 8B) , suggesting that peripheral inflammation might occlude the pronociceptive effect of L-655708. Inhibition of a5-GABA A R activity increased the phosphorylation levels of NMDA receptors and AMPA receptors. The spinal cord slices from intact mice were incubated with a5-GABA A R inverse agonist L-655708 (L-655; 20 nmol/L) for 30 min and then, spinal homogenates were immunoblotted with specific antibodies against phosphorylated GluN1 at Ser896 (pS896, A), phosphorylated GluN2B at Ser1303 (pS1303, B) or phosphorylated GluA1 at Ser831 (pS831, C). The PVDF membranes were stripped and re-probed with antibodies against non-phosphorylated receptors. The graph summarized the percentage change in the phosphorylation level of each subunit. *p < 0.05 relative to ACSF control. n = 6 experiments in each group.
Discussion
Persistent activation of extrasynaptic GABA A Rs by ambient GABA transmitter generates the tonic inhibition, which engages in the regulation of synaptic transmission, neuronal plasticity and information processing (Walker and Semyanov, 2008; Martin et al., 2009; Pofantis and Papatheodoropoulos, 2014) . However, the mechanisms by which these GABA A Rs influence the synaptic efficacy are largely unknown as yet. The current study revealed that there was a functional interplay between a5-GABA A Rs and excitatory glutamate receptors. Normal a5-GABA A Rs activities were critical for the tonic inhibition of glutamate receptor phosphorylation and synaptic distribution. The functional loss of a5-GABA A Rs-mediated tonic inhibition potentiated the glutamatergic transmission, which correlated with pronounced pain hypersensitivity in intact animals.
Previous studies have investigated the role of a5-GABA A Rs in pathological pain, but obtained quite controversial results (Munro et al., 2008 (Munro et al., , 2011 Bravo-Hernandez et al., 2014 de Lucas et al., 2015; Ralvenius et al., 2015) . When L-655708 was peripherally or spinally administrated after peripheral tissue or nerve injury, an analgesic action was observed, suggesting a pronociceptive role played by a5-GABA A Rs (Bravo-Hernandez et al., 2016 ). The Figure 6 GluN2B receptors were required for a5-GABA A R inverse agonist L-655708 to regulate LTP of C fibre-evoked field potentials in spinal cord dorsal horn of rats. (A) L-655708 was first applied onto spinal cord dorsum for 30 min, and then artificial cerebrospinal fluid (ACSF) vehicle, GluN2B antagonist ifenprodil (6 nmol) or GluN2A antagonist TCN-201 (0.2 nmol) was superimposed for additional 30 min before delivery of low-frequency stimulation (LFS; arrow) onto sciatic nerves. The original traces were taken at the time points indicated by number 1 and 2. The percentage changes in the areas under the curves of C fibre-evoked field potentials were plotted against time. *p < 0.05 relative to ACSF vehicle. n = 6 rats in each group. (B) Ifenprodil and TCN-201 had no effect on the basal synaptic transmission. The horizontal bar indicated the period of ifenprodil or TCN-201 application. n = 6 rats in each group. pronociceptive effect might result from the pool of a5-GABA A Rs present at primary afferent fibres (Loeza-Alcocer et al., 2013; Bravo-Hernandez et al., 2016) . At resting conditions, these GABA A Rs generate the primary afferent depolarization (PAD), a process that inhibits the pain sensation by decreasing the release of neurotransmitter from presynaptic terminals (Kullmann et al., 2005) . Some types of injuries might enhance PAD substantially to a level that evokes the action potentials at primary afferent terminals, leading to the shift of PAD from inhibition to excitation (Willis, 1999; Munro et al., 2011) . Noxious inputs might also disrupt the anion homeostasis in nociceptive neurons and switch the hyperpolarizing GABAergic transmission to be depolarizing and excitatory (Coull et al., 2003) . Based on these proposals, GABA A Rs agonists have been observed to aggravate the nociceptive behaviours in some animal models of pain (Munro et al., 2011; Bravo-Hernandez et al., 2014) . Different from these observations, more studies have to date provided evidence that the benzodiazepines specifically acting on a5-GABAARs have the potential for the relief of chronic pain, possibly by activating postsynaptic GABA A Rs and resuming inhibitory GABAergic neurotransmission (Knabl et al., 2008; Ralvenius et al., 2015) .
Concerning the complex of GABA A Rs in nociceptive processing, we simplified our study on a5-GABA A Rs by using intact animals and treating the spinal cord slices in vitro with L-655708. This compound has widely been utilized to reveal the function of a5-GABA A Rs (Atack et al., 2006; Clarkson et al., 2010; Saab et al., 2010; Castro et al., 2011; Wang et al., 2012; Bravo-Hernandez et al., 2014) . When the dose is as low as 20 nmol/L, L-655708 displays a selective affinity for a5-GABA A Rs in vitro (Martin et al., 2009; Clarkson et al., 2010; Wang et al., 2012) . Systemic delivery of L-655708 in vivo at low doses ranging from 200 to 500 lg/kg also blocks a5-GABA A Rs in mice (Clarkson et al., 2010; Wang et al., 2012) . We found that a5-GABA A Rs were persistently active in the negative control of GluA1 phosphorylation at Ser831, which has been shown to hinder the receptor clustering at synapses (DrdlaSchutting et al., 2012) . Once a5-GABA A Rs were inhibited by L-655708, Ser831 phosphorylation was significantly enhanced and the basal synaptic transmission was augmented. By restricting GluN1 and GluN2B phosphorylation, a5-GABA A Rs also suppressed the expression of NMDARs at postsynaptic membrane. These results were in agreement with previous studies showing that the loss of GABAergic inhibition results in the hyperfunction of glutamate receptors (Sorkin et al., 1998; Baba et al., 2003; Buesa et al., 2006; Cao et al., 2011) , and suggested that a5-GABA A Rs were one of the key GABA A Rs subtypes that tonically controlled the glutamatergic conveyance of nociceptive signals.
Previous studies have demonstrated that spinal central sensitization associated with pathological pain is accompanied by two electrophysiological phenomena: windup of action potential firing and LTP of synaptic strength. Windup is a frequency-dependent increase in neuronal excitability caused by repetitive C-fibre stimulation. Specific inhibition of L-type calcium channels, but not NMDARs, attenuates the windup of action potential discharges (Russo and Hounsgaard, 1994) . Repetitive electrical stimulation at C-fibre intensity also The PWL values of intact mice were reduced by L-655708 in a dosedependent manner. Identical volume of artificial cerebrospinal fluid was intrathecally injected as control. *p < 0.05 when compared to baseline. n = 6 mice in each group. (B) L-655708 (0.5 pmol), when intrathecally given one day after intraplantar injection of Complete Freund's Adjuvant (CFA), had no effect on the pain thresholds. *p < 0.05 when compared to baseline. n = 6 mice in each group.
evokes NMDARs-dependent LTP (Ikeda et al., 2006) . Inhibition of NMDARs, especially those containing GluN2B subunit, totally prevents LTP induction (Sandkuhler, 2009 ). Considerable evidence has mounted that GABAergic neurotransmission is able to modulate LTP. Of GABA A Rs subtypes expressed in central nervous system, a5-GABA A Rs are of great interest in that the enhancement of tonic inhibition mediated by a5-GABA A Rs reduces LTP and meanwhile, impairs memory performance (Cheng et al., 2006; Martin et al., 2009) . By contrast, inhibition of a5-GABA A Rs potentiates the glutamatergic neurotransmission (Collinson et al., 2002; Maubach, 2003; Atack et al., 2006; Martin et al., 2009; Pofantis and Papatheodoropoulos, 2014) . Our data demonstrated that a5-GABA A Rs inhibition by L-655708 boosted the phosphorylation and synaptic distribution of GluN2B in spinal dorsal horn. Inhibition of GluN2B, but not GluN2A receptor, abrogated the effect of L-655708 on spinal LTP, suggesting that LTP facilitation by L-655708 required the activation of GluN2B receptors.
The long-lasting synaptic potentiation at C fibreinnervated spinal synapses shares many features with hyperalgesia, and contributes to both acute and chronic pain (Ruscheweyh et al., 2011) . For example, noxious inputs from peripheral injured sites not only cause pain sensitization but evoke robust LTP in vivo (Zhang et al., 2004; Ikeda et al., 2006) . Pharmacological stimulation that is able to induce LTP also leads to hyperalgesia (Ruscheweyh et al., 2011) . Our data showed that spinal L-655708 application boosted the synaptic transmission and facilitated LTP induction. Meanwhile, L-655708 significantly reduced the paw withdrawal latencies in response to thermal stimuli. Notably, non-specific GABA A Rs antagonists, such as bicuculline, resemble L-655708 in the regulation of synaptic efficacy and behavioural responses (Malan et al., 2002; Baba et al., 2003; Buesa et al., 2006; Li et al., 2015) . These observations, in combination with our results, implicated that the synaptic modification by GABAergic tone was closely associated with altered pain sensitivity.
Taken together, the present study reveals an important role of a5-GABA A Rs in the tonic inhibition of nociceptive transmission and plasticity in spinal dorsal horn. Our data suggested that the potentiation of a5-GABA A Rs-meidated inhibition might have therapeutic benefit in pain sensitization.
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